title: Undetectable Urine Calcium in a Gastric Bypass Patient.
authors.affiliation: Department of Pathology and stc2m@virginia.edu.
authors.forename: Sean T
authors.initials: ST
authors.lastname: Campbell
authors.affiliation: Department of Internal Medicine, University of Virginia School of Medicine and Health Sciences Center, Charlottesville, VA.
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Santen
authors.affiliation: Department of Pathology and.
authors.forename: David E
authors.initials: DE
authors.lastname: Bruns
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002117:Calcitriol / Q000008:administration & dosage / Q000493:pharmacokinetics* / Q000627:therapeutic use; D002118:Calcium / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000652:urine*; D004164:Diphosphonates / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D015390:Gastric Bypass / Q000009:adverse effects; D065569:Gastrointestinal Absorption; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy / Q000652:urine*; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid; D002117:Calcitriol; D002118:Calcium